Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
Market Cap 16.12 M P/E(ttm)
Enterprise Value 2.87 M P/B 1.20
CDOM- OTCBB (USA)
Tiger X Medical Inc
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$0.07
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry		 vs
history
Cash to Debt No Debt
CDOM's Cash to Debt is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: No Debt )
CDOM' s 10-Year Cash to Debt Range
Min: No Debt   Max: No Debt
Current: No Debt
Equity to Asset 0.999
CDOM's Equity to Asset is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: 0.999 )
CDOM' s 10-Year Equity to Asset Range
Min: -0.08   Max: 1
Current: 1
-0.08
1
Interest Coverage No Debt
CDOM's Interest Coverage is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: No Debt )
CDOM' s 10-Year Interest Coverage Range
Min: 6   Max: No Debt
Current: No Debt
F-Score: 5
Z-Score: 967.02
M-Score: -4.36
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry		 vs
history
Operating margin (%) -546.80
CDOM's Operating margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: -546.80 )
CDOM' s 10-Year Operating margin (%) Range
Min: -5150   Max: 6.5
Current: -546.8
-5150
6.5
Net-margin (%) 491.9
CDOM's Net-margin (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: 491.9 )
CDOM' s 10-Year Net-margin (%) Range
Min: -457.4   Max: 80516.7
Current: 491.9
-457.4
80516.7
ROE (%) 2.3
CDOM's ROE (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: 2.3 )
CDOM' s 10-Year ROE (%) Range
Min: -75   Max: 74.4
Current: 2.3
-75
74.4
ROA (%) 2.3
CDOM's ROA (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: 2.3 )
CDOM' s 10-Year ROA (%) Range
Min: -52   Max: 70.4
Current: 2.3
-52
70.4
ROC (Joel Greenblatt) (%) -1614.30
CDOM's ROC (Joel Greenblatt) (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: -1614.30 )
CDOM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1614.3   Max: -17.9
Current: -1614.3
-1614.3
-17.9
Revenue Growth (%) -100
CDOM's Revenue Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: -100 )
CDOM' s 10-Year Revenue Growth (%) Range
Min: -100   Max: 24
Current: -100
-100
24
EBITDA Growth (%) -100
CDOM's EBITDA Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: -100 )
CDOM' s 10-Year EBITDA Growth (%) Range
Min: -100   Max: 41.7
Current: -100
-100
41.7
EPS Growth (%) -100
CDOM's EPS Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: -100 )
CDOM' s 10-Year EPS Growth (%) Range
Min: -100   Max: 71.7
Current: -100
-100
71.7
ยป CDOM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with CDOM



No Insider Trades Found!

Ratios

vs
industry		 vs
history
P/B 1.20
CDOM's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: 1.20 )
CDOM' s 10-Year P/B Range
Min: 0.01   Max: 9.2
Current: 1.2
0.01
9.2
P/S 181.82
CDOM's P/S is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: 181.82 )
CDOM' s 10-Year P/S Range
Min: 0.01   Max: 6.52
Current: 181.82
0.01
6.52
EV-to-EBIT 0.2
CDOM's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: 0.2 )
CDOM' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: 0.2

Valuation & Return

vs
industry		 vs
history
Price/Net Cash 1.2
CDOM's Price/Net Cash is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: 1.2 )
CDOM' s 10-Year Price/Net Cash Range
Min: 0.2   Max: 145
Current: 1.2
0.2
145
Price/Tangible Book 1.2
CDOM's Price/Tangible Book is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: 1.2 )
CDOM' s 10-Year Price/Tangible Book Range
Min: 0.1   Max: 48.3
Current: 1.2
0.1
48.3
Price/Graham Number 1.8
CDOM's Price/Graham Number is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: 1.8 )
CDOM' s 10-Year Price/Graham Number Range
Min: 0.3   Max: 1.5
Current: 1.8
0.3
1.5
Earnings Yield (Greenblatt) 580.10
CDOM's Earnings Yield (Greenblatt) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: 580.10 )
CDOM' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0   Max: 406.1
Current: 580.1
0
406.1
Forward Rate of Return (Yacktman) -280.95
CDOM's Forward Rate of Return (Yacktman) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. CDOM: -280.95 )
CDOM' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -220.2   Max: -146.5
Current: -280.95
-220.2
-146.5

Business Description

Tiger X Medical Inc., formerly Cardo Medical, Inc. was incorporated in Delaware. It is an early-stage orthopedic medical device company, which is engaged in the design, development, and marketing of reconstructive joint devices and spinal surgical devices. Reconstructive joint devices are used to replace knee, hip and other joints that have deteriorated through disease or injury. Spinal surgical devices involve products to stabilize the spine for fusion and reconstructive procedures. The Company develops and distributes reconstructive orthopedic and spinal surgery products to various medical organizations. It works in small, focused development teams in conjunction with physicians to rapidly develop products from conception to launch. The Company launched and commenced sales of its first product in late 2006, which was a high-performance, uni-compartmental knee replacement. The Company commenced sales of its reconstructive products in 2007 and spine products in 2008. Its businesses are currently organized into two segments: the Reconstructive Division and the Spine Division. The Reconstructive Division segment is comprised of activity relating to the Company's unicompartmental knee, patello-femoral products, the total knee and hip products. The Spine Division segment is comprised of the spinal lumbar fusion system and cervical plate and screw systems. The Company's current products include: Knee Portfolio, Hip Portfolio and Spinal Product Line. It has a number of earlier stage research and development projects underway, some of which it might submit for regulatory approval in the future. As of March 30, 2009, the Company had two registered trademark with the U.S. Patent and Trademark Office for the marks 'Accin' and 'Align 360'. It has applications pending for the marks 'Cardo Medical' and 'A La Carte.' The orthopedic and spinal device industry is highly competitive and dominated by a number of large companies with greater financial and other resources than the Company has. Its largest competitors in the orthopedic and spinal surgical device market are DePuy Orthopaedics, Inc. and DePuy Spine, Inc., Zimmer, Inc., Stryker Howmedica Osteonics, Smith & Nephew plc, Biomet Orthopedics, Inc., Medtronic Sofamor Danek and Synthes Inc. The Company's products are regulated by the U.S. Food and Drug Administration under the Federal Food, Drug, and Cosmetic Act. Some of its products also are regulated by state agencies.
Company Website
SEC Reports
Industry:
Compare:
ยป More Articles for CDOM

Headlines

Articles On GuruFocus.com

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial